6092
EnBio Holdings,Inc
エンバイオ・ホールディングス
- Industry
- Services
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
6,840,611
Mar 2022
8,987,865
Mar 2023
8,120,309
Mar 2024
9,575,536
Mar 2025
10,668,079
Operating profit(thousand JPY)
Mar 2021
617,904
Mar 2022
1,229,124
Mar 2023
1,357,411
Mar 2024
815,155
Mar 2025
839,454
Operating profit margin(%)
Mar 2021
9.03
Mar 2022
13.68
Mar 2023
16.72
Mar 2024
8.51
Mar 2025
7.87
Profit before tax(thousand JPY)
Mar 2021
488,310
Mar 2022
1,099,319
Mar 2023
1,232,759
Mar 2024
1,065,972
Mar 2025
702,116
Profit(thousand JPY)
Mar 2021
304,060
Mar 2022
654,055
Mar 2023
812,059
Mar 2024
708,764
Mar 2025
452,689
Total assets(thousand JPY)
Mar 2021
15,698,580
Mar 2022
16,370,283
Mar 2023
17,349,955
Mar 2024
19,310,518
Mar 2025
21,195,108
Cash and cash equivalents(thousand JPY)
Mar 2021
1,985,292
Mar 2022
2,341,616
Mar 2023
2,798,635
Mar 2024
3,574,064
Mar 2025
3,263,030
Cash flows from operating activities(thousand JPY)
Mar 2021
297,156
Mar 2022
2,413,152
Mar 2023
1,989,080
Mar 2024
1,663,431
Mar 2025
21,919
Cash flows from investing activities(thousand JPY)
Mar 2021
-2,159,510
Mar 2022
-1,481,400
Mar 2023
-1,770,420
Mar 2024
-1,583,696
Mar 2025
-1,602,974
Cash flows from financing activities(thousand JPY)
Mar 2021
928,537
Mar 2022
-534,925
Mar 2023
240,727
Mar 2024
638,922
Mar 2025
1,274,028
Return on equity(%)
Mar 2021
6
Mar 2022
11.7
Mar 2023
12.8
Mar 2024
9.3
Mar 2025
5.1
Equity ratio(%)
Mar 2021
33.7
Mar 2022
36
Mar 2023
39.1
Mar 2024
44
Mar 2025
43.1
Earnings per share(JPY per share)
Mar 2021
46.22
Mar 2022
98.52
Mar 2023
122.27
Mar 2024
88.85
Mar 2025
55.9
Net assets per share(JPY per share)
Mar 2021
795.22
Mar 2022
886.12
Mar 2023
1,022.7
Mar 2024
1,043.91
Mar 2025
1,128.81
Dividend per share(JPY per share)
Mar 2021
-
Mar 2022
8
Mar 2023
8
Mar 2024
8
Mar 2025
9
Payout ratio(%)
Mar 2021
-
Mar 2022
8.12
Mar 2023
6.54
Mar 2024
9
Mar 2025
16.1
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.